02269.HK
WuXi Biologics (Cayman) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 50.35
+0.50%Next report
Analyst consensus
- Next report date
- Mar 23, 2027
- EPS estimate
- HKD 0.84
- Revenue estimate
- HKD 16.1B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- HKD 0.67
- EPS estimate
- HKD 0.52
- Revenue actual
- HKD 13.6B
- Revenue estimate
- HKD 13.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +28.9%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 25, 2026 | HKD 0.52 | HKD 0.67 | Beat 28.90% | HKD 13.6B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 23, 2027